Comprehensive Cancer Centers of Nevada ( Site 0269) — Las Vegas, Nevada

Comprehensive Cancer Centers of Nevada ( Site 0269) is a clinical research site located in Las Vegas, Nevada, United States 89169.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Comprehensive Cancer Centers of Nevada ( Site 0269) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Hormone-Sensitive Prostate Cancer.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Comprehensive Cancer Centers of Nevada ( Site 0269)?

Comprehensive Cancer Centers of Nevada ( Site 0269) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Comprehensive Cancer Centers of Nevada ( Site 0269) conducted?

Comprehensive Cancer Centers of Nevada ( Site 0269) has 1 clinical trials on record, with 1 currently active. Their work covers Metastatic Hormone-Sensitive Prostate Cancer.

Is Comprehensive Cancer Centers of Nevada ( Site 0269) accredited by Crixeo Health?

Comprehensive Cancer Centers of Nevada ( Site 0269) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Comprehensive Cancer Centers of Nevada ( Site 0269)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.